{
  "id": 3477,
  "text": "Modern Oncol 19, 1827-1830 (2011).1448.Wan, Y.H., et al.Curative effect of cisplatin or paclitaxel in concurrent chemoradiotherapy for cervical cancer: a report of 58 cases.J Chin Tradit Chin Med Inform 3, 162 (2011).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Modern Oncol 19, 1827-1830 (2011).1448.Wan, Y.H., et al.Curative effect of cisplatin or paclitaxel in concurrent chemoradiotherapy for cervical cancer: a report of 58 cases.J Chin Tradit Chin Med Inform 3, 162 (2011).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "顺铂和紫杉醇在同步放化疗中对宫颈癌具有显著疗效。根据相关研究，顺铂常作为同步放化疗的核心药物，能够增强肿瘤对放射治疗的敏感性，并提高治疗效果。同时，紫杉醇也显示出良好的抗肿瘤作用，尤其在部分病例中可以作为辅助方案，进一步改善疗效。这两种药物在临床实践中得到了广泛认可，是宫颈癌患者同步放化疗的重要选择。",
  "query": "什么药物在同步放化疗中对宫颈癌具有显著疗效？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么药物在同步放化疗中对宫颈癌具有显著疗效？\n\n<reference text>: Modern Oncol 19, 1827-1830 (2011).1448.Wan, Y.H., et al.Curative effect of cisplatin or paclitaxel in concurrent chemoradiotherapy for cervical cancer: a report of 58 cases.J Chin Tradit Chin Med Inform 3, 162 (2011).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "顺铂和紫杉醇在同步放化疗中对宫颈癌具有显著疗效。根据相关研究，顺铂常作为同步放化疗的核心药物，能够增强肿瘤对放射治疗的敏感性，并提高治疗效果。同时，紫杉醇也显示出良好的抗肿瘤作用，尤其在部分病例中可以作为辅助方案，进一步改善疗效。这两种药物在临床实践中得到了广泛认可，是宫颈癌患者同步放化疗的重要选择。"
}